|
0
|
|
Your neighbors matter: Adjacent cancer cells dampen TLS function.
(linkinghub.elsevier.com)
|
Salgia NJ
…
Muhitch JB
Cancer Cell
2026-07-09
|
#cancer
#immunotherapy
#immunosuppression
#microenvironment
|
|
0
|
|
GABA promotes resistance to immunotherapy in patients with TLS-positive tumors.
(linkinghub.elsevier.com)
|
Hernandez-Verdin I
…
Fridman WH
Cancer Cell
2026-07-09
|
#cancer
#immunotherapy
#immunosuppression
#immunometabolism
#multi-omics
|
|
0
|
|
A micropeptide encoded by the lncRNA USP30-AS1 promotes tumor growth by attenuating cGAS-STING-type I IFN signaling in macrophages.
(nature.com)
|
Wang X
…
Hu Y
Nature Cancer
2026-07-09
|
#cancer
#immunotherapy
#macrophage
#ncrna
#interferon
|
|
0
|
|
Targeting LIG1 to overcome oxaliplatin resistance by inducing PANoptosis in colorectal cancer.
(linkinghub.elsevier.com)
|
Gao Q
…
Sui X
Drug Resistance Updates
2026-07-09
|
#colorectal cancer
#chemoresistance
#immunotherapy
#apoptosis
#drug discovery
|
|
0
|
|
Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.
(linkinghub.elsevier.com)
|
Davids MS
…
Wierda WG
The Lancet
2026-07-09
|
#leukemia
#clinical trial
#lymphoma
#immunotherapy
#pharmacotherapy
|
|
0
|
|
The CARM1 epigenetic enzyme inhibits cross-presenting dendritic cell function in cancer immunity.
(science.org)
|
Zhang X
…
Wucherpfennig KW
Science
2026-07-09
|
#cancer
#immunotherapy
#dendritic cell
#epigenetics
#antigen-presentation
|